Table 3. Phenotypes reported for dysbindin-deficient cell lines (neuroblastoma or pheochromocytoma) and primary neurons in culture*.
| RNAi controls | |||||
|---|---|---|---|---|---|
| Cell type | Dysbindin deficiency by | Efficacy | Off-target effects | Observed phenotype(s) | Reference |
| Immortalized cell lines | |||||
| PC12 | siRNA | IB | Not shown | ↑ Evoked dopamine secretion; ↑ SNAP25 protein | Kumamoto et al. (2006) |
| SH-SY5Y | siRNA | IB | siRNA to muted | ↑ DRD2 at cell surface; ↓ CREB phosphorylation (basal and induced) | Iizuka et al. (2007) |
| Not shown | ↓ Neurite outgrowth; abnormal actin cytoskeleton at neurite tip; ↓ JNK phosphorylation | Kubota et al. (2009) | |||
| IB to FLAG | Not shown | ↑ MARCKS mRNA and protein | Okuda et al. (2010) | ||
| N2a | siRNA | IB | Not shown | ↓ Synapsin I protein | Fei et al. (2010) |
| Primary neurons | |||||
| Cortical, rat | siRNA | IB | Not shown | ↓ SNAP25 and synapsin I proteins; ↓ Akt phosphorylation; ↓ glutamate release; ↑ cell death upon serum withdraw | Numakawa et al. (2004) |
| ↑ DRD2 at cell surface; ↓ quinpirole-induced CREB phosphorylation | Iizuka et al. (2007) | ||||
| Cortical, mouse | Dtnbp1sdy | N/A | N/A | ↑ DRD2 at cell surface; ↑ recycling of internalized DRD2 | Ji et al. (2009) |
| ↑ NR2A and ↓ NR2B at cell surface | Tang et al. (2009b) | ||||
| Hippocampal, mouse | Dtnbp1sdy | N/A | N/A | ↑ Exogenous NR2A-GFP at cell surface | Tang et al. (2009b) |
| Abnormal cytoskeleton at growth cone; ↓ JNK phosphorylation | Kubota et al. (2009) | ||||
| Pldnpa | N/A | N/A | ↓ Neurite outgrowth | Ghiani et al. (2010) | |
| Hippocampal, rat | shRNA | IB, IF | Two shRNAs; rescue | ↓ Dendritic spine maturation | Ito et al. (2010) |
Cells deficient in dysbindin were obtained by RNAi or by primary culture of neurons from homozygous ‘sandy’ (Dtnbp1sdy) or ‘pallid’ (Pldnpa) mice, with the latter carrying a null mutation in a BLOC-1 subunit (causing secondary deficiency in dysbindin). The efficacy of RNAi was verified on the endogenous dysbindin in all cases except where 'IB to FLAG' denotes that it was tested using a transfected dysbindin-FLAG construct. DRD2, dopamine D2 receptor; IB, immunoblotting; IF, immunofluorescence; N/A, not applicable; shRNA, short-harpin RNA; siRNA, small-interfering RNA; GFP, green fluorescent protein; CREB, cAMP-response-element-binding protein; MARCKS, myristoylated alanine-rich C-kinase substrate; SNAP25, synaptosome-associated protein of 25 kDa.